FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Bias

Research Profile

Chemicals & Drugs

Disorders

Procedures

Administration, Oral

Concepts & Ideas

Objects

Microspheres

Anatomy

Digestive System

Co-author Network

Publications

TOP 3
Max Reinshagen; Ekkehard Schütz; Victor W Armstrong; Christoph Behrens; Christian von Tirpitz; Andreas Stallmach; Hans Herfarth; Jürgen Stein; Peter Bias; Guido Adler; Maria Shipkova; Wolfgang Kruis; Michael Oellerich; Nicolas Von Ahsen
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
Nicolas Von Ahsen; Victor W Armstrong; Christoph Behrens; Christian von Tirpitz; Andreas Stallmach; Hans Herfarth; Jürgen Stein; Peter Bias; Guido Adler; Maria Shipkova; Michael Oellerich; Wolfgang Kruis; Max Reinshagen; Ekkehard Schütz
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.
Andreas Raedler; C Behrens; Peter Bias
Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Bias (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Max Reinshagen; Ekkehard Schütz; Victor W Armstrong; Christoph Behrens; Christian von Tirpitz; Andreas Stallmach; Hans Herfarth; Jürgen Stein; Peter Bias; Guido Adler; Maria Shipkova; Wolfgang Kruis; Michael Oellerich; Nicolas Von Ahsen
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
Clinical chemistry 2007;53(7):1306-14.
2005: Nicolas Von Ahsen; Victor W Armstrong; Christoph Behrens; Christian von Tirpitz; Andreas Stallmach; Hans Herfarth; Jürgen Stein; Peter Bias; Guido Adler; Maria Shipkova; Michael Oellerich; Wolfgang Kruis; Max Reinshagen; Ekkehard Schütz
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.
Clinical chemistry 2005;51(12):2282-8.
2004: Andreas Raedler; C Behrens; Peter Bias
Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.
Alimentary pharmacology & therapeutics 2004;20(11-12):1353-63.
2003: Ian R Wilding; C Behrens; S J Tardif; Heather Wray; Peter Bias; W Albrecht
Combined scintigraphic and pharmacokinetic investigation of enteric-coated mesalazine micropellets in healthy subjects.
Alimentary pharmacology & therapeutics 2003;17(9):1153-62.